```html

Quick‑Acting Insulin Overdose

Overview

Quick‑acting insulin (also called rapid‑acting insulin) is a short‑duration formulation—such as insulin lispro (Humalog®), insulin aspart (Novolog®), or insulin glulisine (Apidra®)—that begins to lower blood glucose within 10–15 minutes, peaks at about 1 hour, and lasts 3–5 hours. An overdose occurs when the amount administered exceeds what the body needs for the current carbohydrate intake, physical activity level, or basal insulin coverage.

Quick‑acting insulin overdose is most often seen in people with type 1 diabetes (who use multiple daily injections or pumps) but can also affect individuals with type 2 diabetes who rely on rapid‑acting bolus insulin. Accidental overdose can be life‑threatening because it precipitates severe hypoglycemia.

Prevalence: Exact rates are difficult to capture, but a review of emergency‑department (ED) data in the United States reported that approximately 1.5 % of all diabetes‑related ED visits involve insulin‑induced hypoglycemia, with a substantial proportion due to rapid‑acting formulations. Intentional overdose (e.g., self‑harm) accounts for roughly 10–15 % of these cases, while the remainder are accidental (mis‑dosing, missed meals, or exercise mismatches)【1】.

Symptoms

Symptoms reflect falling blood glucose (hypoglycemia) and appear in a predictable order, though severity varies with the degree of overdose.

• Adrenergic (early) signs – occur when glucose < 70 mg/dL (3.9 mmol/L):
  • Shakiness, tremor
  • Palpitations or racing heart
  • Sweating (diaphoresis)
  • Anxiety, feeling “jumpy”
  • Pallor, cold clammy skin
• Neuroglycopenic (later) signs – develop as glucose falls < 50 mg/dL (2.8 mmol/L):
  • Confusion, difficulty concentrating
  • Blurred vision
  • Slurred speech, dysarthria
  • Headache
  • Weakness, fatigue
• Severe neuroglycopenia – glucose < 30 mg/dL (1.7 mmol/L) or rapid drop:
  • Seizures
  • Loss of consciousness
  • Coma
  • Potential brain injury if prolonged
• Behavioural changes (often reported by friends/family):
  • Irritability or aggression
  • Unusual sleepiness

Causes and Risk Factors

Common Causes

• Incorrect dose calculation – mis‑reading carbohydrate‑to‑insulin ratios, using the wrong correction factor, or accidentally double‑dosing.
• Missed or delayed meals after a bolus has been injected.
• Unexpected physical activity – exercise increases insulin sensitivity and glucose uptake, amplifying the insulin effect.
• Alcohol consumption – impairs gluconeogenesis and can mask early hypoglycemia symptoms.
• Medication interactions – e.g., β‑blockers blunt adrenergic warning signs; certain antibiotics (e.g., quinolones) may heighten insulin sensitivity.
• Insulin pump malfunction – delivery of an unintended bolus or continuous over‑infusion.
• Intentional overdose – as a suicide attempt or self‑harm.

Risk Factors

• Type 1 diabetes with intensive insulin regimens.
• Newly diagnosed patients still learning dose calculations.
• Elderly individuals with cognitive impairment or visual deficits.
• Patients with renal or hepatic dysfunction (reduced insulin clearance).
• Pregnant women, because insulin requirements change rapidly.
• Individuals with co‑existing mental health conditions (depression, anxiety, substance use).

Diagnosis

Diagnosis is clinical, supported by bedside testing and, when needed, laboratory work.

1. Rapid glucose assessment

• Capillary (finger‑stick) glucose < 70 mg/dL with compatible symptoms strongly suggests insulin‑induced hypoglycemia.
• If the patient is unconscious, a point‑of‑care glucometer or a bedside laboratory plasma glucose measurement is required.

2. History and physical exam

• Ask about recent insulin doses, timing of meals, activity, alcohol intake, and any pump alerts.
• Review mental health history for possible intentional overdose.

3. Laboratory tests (if the presentation is atypical or severe)

• Serum glucose, electrolytes, and renal function.
• C‑peptide (usually suppressed in exogenous insulin overdose).
• Insulin levels – markedly elevated compared with endogenous secretion.
• Beta‑hydroxybutyrate – typically low in insulin‑induced hypoglycemia (vs. starvation ketoacidosis).

4. Imaging (rare)

If seizures or prolonged coma occur, a CT or MRI may be performed to exclude intracranial pathology.

Treatment Options

Treatment aims to raise blood glucose quickly, sustain normal levels, and prevent recurrence.

Immediate Management

1. Oral glucose (if patient is awake & can swallow)
   • 15 g of fast‑acting carbohydrate (e.g., glucose tablets, regular soda, juice).
   • Re‑check glucose after 15 minutes; repeat until ≥ 70 mg/dL.
2. Glucagon administration (if patient is unconscious, seizing, or cannot ingest carbs)
   • Intramuscular (IM) or subcutaneous (SC) dose: 1 mg (adult); 0.5 mg for children < 25 kg.
   • Newer ready‑to‑use nasal glucagon (3 mg) is an alternative for adults and older children.
   • Repeat after 15 minutes if glucose remains < 70 mg/dL.
3. Intravenous dextrose (hospital setting)
   • For severe hypoglycemia (glucose < 40 mg/dL) or altered mental status: 25 g of 50 % dextrose (D50W) IV push.
   • Follow with a continuous infusion of 5–10 % dextrose (D5W/D10W) to maintain glucose 70–150 mg/dL for 1–2 hours.

Monitoring

• Continuous glucose monitoring (CGM) or hourly finger‑sticks for at least 4–6 hours.
• Observe for rebound hypoglycemia 2–4 hours after initial treatment, especially after IV dextrose.

Adjunctive Therapies

• Octreotide – a somatostatin analog that suppresses insulin release; may be considered in rare cases of endogenous hyperinsulinemia but not useful for pure exogenous overdose.
• Hydration – isotonic saline if the patient is volume depleted.

Long‑Term Adjustments

• Review and adjust insulin‑to‑carbohydrate ratios, correction factors, and basal rates.
• Education on meal timing, snack strategies, and exercise‑dose modifications.
• Psychiatric evaluation if intentional overdose is suspected.

Living with Quick‑Acting Insulin Overdose

Daily Management Tips

• Use a reliable dosing calculator – many pumps and smartphone apps have built‑in calculators; double‑check before each bolus.
• Set reminders for meals, especially when you have a busy schedule.
• Carry rapid‑acting carbs at all times (e.g., glucose tablets, candy, juice).
• Wear medical identification that notes you use rapid‑acting insulin.
• Monitor glucose frequently during changes in routine (new exercise, travel, illness).
• Maintain a “sick‑day” plan that includes dose reduction guidelines for reduced appetite.
• Educate family, friends, and coworkers on recognizing hypoglycemia and administering glucagon.
• Review CGM alerts and set low‑glucose thresholds slightly higher (e.g., 80 mg/dL) if you have a tendency to overshoot.

Psychosocial Considerations

Living with a condition that carries a risk of acute overdose can cause anxiety. Access to diabetes counseling, peer‑support groups, and mental‑health resources improves adherence and reduces intentional misuse.

Prevention

• Education & re‑training – Annual review of insulin‑carbohydrate counting and pump settings.
• Standardized dose‑verification – “Check‑check‑chek” method: check the dose, the insulin type, and the timing before injection.
• Safe storage – Keep insulin pens/pumps separate from other medications to avoid accidental double‑dosing.
• Technology aids – Use CGM alarms, insulin‑pump safety features (e.g., “bolus‑clear” before delivery), and smartphone reminders.
• Alcohol moderation – Limit intake and always pair with carbs.
• Exercise planning – Reduce bolus by 10–20 % for moderate activity lasting > 30 minutes; increase carbs if activity is prolonged.
• Regular follow‑up – Quarterly visits with a diabetes educator and endocrinologist to fine‑tune regimens.

Complications

If untreated or inadequately treated, quick‑acting insulin overdose can lead to:

• Severe hypoglycemia → seizures, irreversible brain injury, or death.
• Cardiac arrhythmias due to catecholamine surge.
• Falls and traumatic injuries (especially in older adults).
• Secondary hyperglycemia after rebound treatment, potentially precipitating ketosis in type 1 diabetes.
• Psychiatric sequelae: anxiety, depression, or development of disordered eating patterns around insulin (e.g., “insulin‑pumping bulimia”).

According to the CDC, severe hypoglycemia accounts for ~4 % of diabetes‑related deaths in the United States, underscoring the seriousness of overdose events【2】.

When to Seek Emergency Care

---

References

1. American Diabetes Association. Standards of Medical Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S1‑S350. DOI:10.2337/dc24-SINT.
2. Centers for Disease Control and Prevention. Diabetes Complications and Mortality. Updated 2023.
3. Mayo Clinic. Hypoglycemia. Accessed June 2024.
4. World Health Organization. Diabetes Fact Sheet. 2023.
5. Cleveland Clinic. Hypoglycemia (Low Blood Sugar). 2024.
6. Hirsch IB, et al. “Insulin Overdose: Clinical Presentation and Management.” *J Clin Endocrinol Metab.* 2022;107(5):1485‑1494. DOI:10.1210/clinem/dgac098.

```